Indefinite Delivery Contract SPE2D020D0011

The Defense Logistics Agency (DLA) Troop Support Medical awarded Akorn, Inc. a single-award indefinite delivery contract (IDC) with a ceiling value of $42,084,863.92 to supply pharmaceutical products in support of DLA programs. Under this contract, Akorn has received numerous firm fixed price delivery orders to provide naloxone injection solution, an opioid overdose reversal medication, to DLA's facility in Lake Forest, Illinois. The delivery orders range in value from $83 to $498 and require Akorn to deliver hundreds of thousands of units of naloxone by specified dates through 2023. As the prime contractor, Akorn's reliable supply of this critical pharmaceutical directly aids DLA's efforts to ensure military treatment facilities worldwide have rapid access to emergency overdose treatment. This IDC supports DLA Troop Support Medical's mission to procure and provision Class VIII medical supplies to all branches of the U.S. Armed Forces.

Additionally, Akorn has been awarded multiple delivery orders against the IDC to supply varying quantities of naloxone injection solution, with no set-aside designations applied. These firm fixed price orders, ranging from $83 to $498, require Akorn to deliver the naloxone to DLA's Lake Forest, Illinois facility by dates through early 2023. The delivery of this opioid overdose reversal medication aligns with DLA Troop Support Medical's responsibility to provision medical supplies and equipment in support of the healthcare needs of military personnel.